BioSpace News Archive

Bausch + Lomb Corporation today announced its ONE by ONE and Biotrue ® Eye Care Recycling programs have collected 84,343,540 units, or 510,116 pounds, of used contact lenses, eye care and lens care materials in the U.S.

GenSight Biologics today announced the filing of its 2023 Universal Registration Document (URD) in English with the French market authority (Autorités des Marchés Financiers , or AMF) under the reference D.24-0299.

CureVac N.V. will report financial results, and provide business updates for the fourth quarter and full-year 2023 on Wednesday, April 24, 2024.

Paratek Pharmaceuticals, Inc. today announced that three new pre-clinical studies with NUZYRA ® (omadacycline) will be presented at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global, formerly ECCMID).

Benitec Biopharma Inc. today announces positive interim clinical data from the 90-day timepoint following the administration of BB-301 to the study’s first subject (Subject 1) treated in the BB-301 Phase 1b/2a single-arm, open-label, sequential, dose-escalation cohort study (NCT06185673) in Oculopharyngeal Muscular Dystrophy (OPMD).

Biomed Israel , the premier international Life Science and HealthTech conference in Israel , will take place on May 21-23, 2024 , at the David InterContinental Hotel in Tel Aviv, Israel.

Redwood Scientific Technologies Inc. (OTC: RSCI) (“Redwood” or “the Company”), a pharmaceutical company, today announced a strategic shift in its product development priorities.

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry.

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility.

Ardelyx, Inc today announced it will hold a conference call on Thursday, May 2, 2024, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2024.